Russell Angus C.

Russell Angus C. is listed in filings as Director at Lineage Cell Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jul 2, 2025, including 6 public disclosures. Recent filings connect the profile to Lineage Cell Therapeutics, Inc. (LCTX), Structure Therapeutics Inc (GPCR), and Revance Therapeutics, Inc. - Common Stock (RVNC). The current snapshot covers public activity from Jul 3, 2024 to Jul 2, 2025. Reported amounts are shown as $67.3K to $133.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.